Biomarkers in endometrial cancer: Possible clinical applications (Review)
Kouji Banno(Keio University), Daisuke Aoki(International University of Health and Welfare), Iori Kisu(Fujita Health University), Yusuke Kobayashi(University of Tsukuba), Hiroyuki Nomura(Keio University), Eiichiro Tominaga(Keio University), Arisa Ueki(Keio University), Nobuyuki Susumu(Keio University), Megumi Yanokura(Keio University), Kenta Masuda(Keio University), Kosuke Tsuji(Keio University), Wataru Yamagami(Keio University)
Cited by 47
Related Papers
Pathological Steps of Cancer-Related Lymphedema: Histological Changes in the Collecting Lymphatic Vessels after Lymphadenectomy
|PLoS ONE|2012|331
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|214
MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
|The Scientific World JOURNAL|2014|143
Cross‐sectional analysis of germline <i>BRCA</i>1 and <i>BRCA</i>2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
|Cancer Science|2008|105
Registry of the International Society of Uterus Transplantation: First Report
|Transplantation|2022|100